EM || News

TNF blocker adalimumab approved for pediatric Crohn’s disease

Posted on: 25/09/2014 - 22:05

The tumor necrosis factor blocker adalimumab is now approved for treating children with Crohn’s disease, down to age 6 years, AbbVie, the manufacturer, announced on Sept. 25. The approved...

Field of Interest: Gastroentero...

Type: News Item

Less than 20% report serious disability 13 years after IBD diagnosis

Posted on: 01/08/2014 - 05:01

Only a minority of patients with longstanding inflammatory bowel disease – 19% of those with Crohn’s disease and 11% of those with ulcerative colitis – report having moderate to severe disability,...

Field of Interest: Gastroentero...

Type: News Item

Emergency physicians may be overprescribing PPIs

Posted on: 23/07/2014 - 21:00

DALLAS – The frequency at which U.S. emergency department physicians prescribed proton pump inhibitors more than doubled during 2001-2010, despite mounting safety concerns surrounding this class of...

Field of Interest: Gastroentero...

Type: News Item

Seven percent of patients with life-threatening skin reactions have another episode

Posted on: 03/06/2014 - 21:00

Patients who survived Stevens-Johnson syndrome or toxic epidermal necrolysis had a 7% incidence of recurrence, based on data from a 10-year population study of more than 500 Canadian patients. The...

Field of Interest: Dermatology

Type: News Item

FDA approves dalbavancin for acute bacterial skin infections

Posted on: 23/05/2014 - 22:20

Dalbavancin is the first drug with a Qualified Infectious Disease Product designation to be approved by the Food and Drug Administration. On May 23, the agency approved dalbavancin (<link...

Field of Interest: Dermatology

Type: News Item

FDA rejects serelaxin for acute heart failure

Posted on: 16/05/2014 - 21:45

The Food and Drug Administration has decided that more evidence of serelaxin’s efficacy as a treatment for acute heart failure is needed before the drug can be approved in the United States, Novartis...

Field of Interest: Cardiology

Type: News Item

Longer-term opioid use in workers’ comp cases highest in Louisiana

Posted on: 15/05/2014 - 19:30

In Louisiana, opioid use lasted more than 6 months in 17% of nonsurgical workers’ compensation claims involving employees who received at least one prescription for pain medication, the Workers...

Field of Interest: Rheumatology

Type: News Item

FDA declines to approve IV antiplatelet drug cangrelor

Posted on: 08/05/2014 - 22:15

The Food and Drug Administration has rejected the approval of the intravenous antiplatelet drug cangrelor, suggesting that the company provide more data, according to the drug’s manufacturer. The...

Field of Interest: Cardiology

Type: News Item

INR test strips recalled due to reports of inaccurate results

Posted on: 07/05/2014 - 17:10

Professional international normalized ratio test strips manufactured by Alere are being recalled because of reports of "inaccurately low" results, including several cases of...

Field of Interest: Cardiology

Type: News Item

Vast majority of ED visits for acute heart failure become admissions

Posted on: 30/04/2014 - 20:30

Nearly six of every seven patients presenting to U.S. emergency departments with acute heart failure are admitted. This means acute heart failure is "a major challenge" to emergency...

Field of Interest: Cardiology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters